{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:14:09Z","timestamp":1790723649684,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1138165"],"award-info":[{"award-number":["APP1138165"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bacterial vaginosis (BV) is estimated to affect 1 in 3 women globally and is associated with obstetric and gynaecological sequelae. Current recommended therapies have good short-term efficacy but 1 in 2 women experience BV recurrence within 6\u2009months of treatment. Evidence of male carriage of BV-organisms suggests that male partners may be reinfecting women with BV-associated bacteria (henceforth referred to as BV-organisms) and impacting on the efficacy of treatment approaches solely directed to women. This trial aims to determine the effect of concurrent male partner treatment for preventing BV recurrence compared to current standard of care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>StepUp is an open-label, multicentre, parallel group randomised controlled trial for women diagnosed with BV and their male partner. Women with clinical-BV defined using current gold standard diagnosis methods (\u22653 Amsel criteria and Nugent score (NS)\u2009=\u20094\u201310) and with a regular male partner will be assessed for eligibility, and couples will then be consented. All women will be prescribed oral metronidazole 400\u2009mg twice daily (BID) for 7\u2009days, or if contraindicated, a 7-day regimen of topical vaginal 2% clindamycin. Couples will be randomised 1:1 to either current standard of care (female treatment only), or female treatment and concurrent male partner treatment (7\u2009days of combined antibiotics - oral metronidazole tablets 400\u2009mg BID and 2% clindamycin cream applied topically to the glans penis and upper shaft [under the foreskin if uncircumcised] BID). Couples will be followed for up to 12\u2009weeks to assess BV status in women, and assess the adherence, tolerability and acceptability of male partner treatment. The primary outcome is BV recurrence defined as \u22653 Amsel criteria and NS\u2009=\u20094\u201310 within 12\u2009weeks of enrolment. The estimated sample size is 342 couples, to detect a 40% reduction in BV recurrence rates from 40% in the control group to 24% in the intervention group within 12\u2009weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Current treatments directed solely to women result in unacceptably high rates of BV recurrence. If proven to be effective the findings from this trial will directly inform the development of new treatment strategies to impact on BV recurrence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The trial was prospectively registered on 12 February 2019 on the Australian and New Zealand Clinical Trial Registry (ACTRN12619000196145, Universal Trial Number: U1111\u20131228-0106, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=376883&amp;isReview=true\">https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=376883&amp;isReview=true<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05563-w","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T13:03:03Z","timestamp":1605099783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence"],"prefix":"10.1186","volume":"20","author":[{"name":"on behalf of the StepUp RCT Team","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-9195","authenticated-orcid":false,"given":"Lenka A.","family":"Vodstrcil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"McGuiness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Bateson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Petoumenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P. F.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona S.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"issue":"5","key":"5563_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","volume":"46","author":"K Peebles","year":"2019","unstructured":"Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019;46(5):304\u201311.","journal-title":"Sex Transm Dis"},{"key":"5563_CR2","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S0020-7292(99)00136-8","volume":"67","author":"EH Koumans","year":"1999","unstructured":"Koumans EH, Markowitz LE, Berman SM, St Louis ME. A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis. Int J Gynaecol Obstet. 1999;67:S29\u201333.","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"5563_CR3","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1086\/657320","volume":"202","author":"RM Brotman","year":"2010","unstructured":"Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J, Schwebke JR. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010;202(12):1907\u201315.","journal-title":"J Infect Dis"},{"issue":"6","key":"5563_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001251","volume":"9","author":"CR Cohen","year":"2012","unstructured":"Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012;9(6):e1001251.","journal-title":"PLoS Med"},{"issue":"2","key":"5563_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/civ298","volume":"61","author":"L Masson","year":"2015","unstructured":"Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, et al. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015;61(2):260\u20139.","journal-title":"Clin Infect Dis"},{"issue":"RR-3","key":"5563_CR6","first-page":"69","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA. Sexually Transmitted Disease Treatment Guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-3):69\u201372.","journal-title":"MMWR Recomm Rep"},{"key":"5563_CR7","first-page":"CD006055","volume":"3","author":"OO Oduyebo","year":"2009","unstructured":"Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. The Cochrane database of systematic reviews. 2009;3:CD006055.","journal-title":"The Cochrane database of systematic reviews"},{"key":"5563_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Fairley CK. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193:1478\u201389.","journal-title":"J Infect Dis"},{"issue":"8","key":"5563_CR9","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","volume":"17","author":"M Unemo","year":"2017","unstructured":"Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17(8):e235\u201379.","journal-title":"Lancet Infect Dis"},{"issue":"448","key":"5563_CR10","first-page":"913","volume":"49","author":"J Potter","year":"1999","unstructured":"Potter J. Should sexual partners of women with bacterial vaginosis receive treatment? Br J Gen Pract. 1999;49(448):913\u20138.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"5563_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/0002-9378(55)90095-8","volume":"69","author":"HL Gardner","year":"1955","unstructured":"Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955;69(5):962\u201376.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"5563_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jama.1985.03360080058029","volume":"254","author":"J Swedberg","year":"1985","unstructured":"Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. Jama. 1985;254(8):1046\u20139.","journal-title":"Jama"},{"issue":"9","key":"5563_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1471-0528.1988.tb06581.x","volume":"95","author":"M Vejtorp","year":"1988","unstructured":"Vejtorp M, Bollerup AC, Vejtorp L, Fanoe E, Nathan E, Reiter A, Andersen ME, Stromsholt B, Schroder SS. Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner. Br J Obstet Gynaecol. 1988;95(9):920\u20136.","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"5563_CR14","first-page":"163","volume":"28","author":"MB Mengel","year":"1989","unstructured":"Mengel MB, Berg AO, Weaver CH, Herman DJ, Herman SJ, Hughes VL, Koepsell TD. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J Fam Pract. 1989;28(2):163\u201371.","journal-title":"J Fam Pract"},{"issue":"4","key":"5563_CR15","first-page":"263","volume":"65","author":"H Moi","year":"1989","unstructured":"Moi H, Erkkola R, Jerve F, Nelleman G, Bymose B, Alaksen K, Tornqvist E. Should male consorts of women with bacterial vaginosis be treated? Genitourin Med. 1989;65(4):263\u20138.","journal-title":"Genitourin Med"},{"issue":"4 Pt 1","key":"5563_CR16","first-page":"550","volume":"82","author":"T Vutyavanich","year":"1993","unstructured":"Vutyavanich T, Pongsuthirak P, Vannareumol P, Ruangsri RA, Luangsook P. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet Gynecol. 1993;82(4 Pt 1):550\u20134.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"5563_CR17","first-page":"267","volume":"73","author":"E Colli","year":"1997","unstructured":"Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med. 1997;73(4):267\u201370.","journal-title":"Genitourin Med"},{"issue":"10","key":"5563_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/OLQ.0b013e3182631d89","volume":"39","author":"SD Mehta","year":"2012","unstructured":"Mehta SD. Systematic review of randomized trials of treatment of male sexual Partners for Improved Bacterial Vaginosis Outcomes in women. Sex Transm Dis. 2012;39(10):822\u201330.","journal-title":"Sex Transm Dis"},{"key":"5563_CR19","first-page":"CD011701","volume":"10","author":"J Amaya-Guio","year":"2016","unstructured":"Amaya-Guio J, Viveros-Carreno DA, Sierra-Barrios EM, Martinez-Velasquez MY, Grillo-Ardila CF. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Datab Syst Rev. 2016;10:CD011701.","journal-title":"Cochrane Datab Syst Rev"},{"issue":"6","key":"5563_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cid\/cis1030","volume":"56","author":"CS Bradshaw","year":"2013","unstructured":"Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM, De Guingand D, Morton AN, Fairley CK. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis. 2013;56(6):777\u201386.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5563_CR21","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41598-019-39879-8","volume":"9","author":"LA Vodstrcil","year":"2019","unstructured":"Vodstrcil LA, Plummer ME, Fairley CK, Tachedjian G, Law MG, Hocking JS, Worthington MK, Grant MM, Okoko N, Bradshaw CS. Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial. Sci Rep. 2019;9(1):3555.","journal-title":"Sci Rep"},{"issue":"3","key":"5563_CR22","doi-asserted-by":"publisher","first-page":"e00589","DOI":"10.1128\/mBio.00589-15","volume":"6","author":"CM Liu","year":"2015","unstructured":"Liu CM, Hungate BA, Tobian AA, Ravel J, Prodger JL, Serwadda D, Kigozi G, Galiwango RM, Nalugoda F, Keim P, et al. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. mBio. 2015;6(3):e00589.","journal-title":"mBio"},{"issue":"5","key":"5563_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036298","volume":"7","author":"DE Nelson","year":"2012","unstructured":"Nelson DE, Dong Q, Van Der Pol B, Toh E, Fan B, Katz BP, Mi D, Rong R, Weinstock GM, Sodergren E, et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One. 2012;7(5):e36298.","journal-title":"PLoS One"},{"key":"5563_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fcimb.2020.00433","volume":"10","author":"SD Mehta","year":"2020","unstructured":"Mehta SD, Zhao D, Green SJ, Agingu W, Otieno F, Bhaumik R, Bhaumik D, Bailey RC. The Microbiome Composition of a Man's Penis Predicts Incident Bacterial Vaginosis in His Female Sex Partner With High Accuracy. Front Cell Infect Microbiol. 2020;10:433.","journal-title":"Front Cell Infect Microbiol"},{"key":"5563_CR25","doi-asserted-by":"crossref","unstructured":"Mehta SD, Agingu W, Nordgren RK, Green SJ, Bhaumik DK, Bailey RC, Otieno F. Characteristics of women and their male sex partners predict bacterial vaginosis among a prospective cohort of Kenyan women with non-optimal vaginal microbiota. Sex Transm Dis. 2020.","DOI":"10.1097\/OLQ.0000000000001259"},{"issue":"1","key":"5563_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40168-016-0161-6","volume":"4","author":"M Zozaya","year":"2016","unstructured":"Zozaya M, Ferris MJ, Siren JD, Lillis R, Myers L, Nsuami MJ, Eren AM, Brown J, Taylor CM, Martin DH. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome. 2016;4(1):16.","journal-title":"Microbiome"},{"key":"5563_CR27","doi-asserted-by":"crossref","unstructured":"Ratten L, Plummer E, Murray G, Danielewski J, Fairley C, Garland S, Hocking J, Tachedjian G, Chow E, Bradshaw C et al: Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study. BJOG2020, n\/a(n\/a).","DOI":"10.1111\/1471-0528.16430"},{"issue":"5","key":"5563_CR28","first-page":"567","volume":"29","author":"A Swidsinski","year":"2014","unstructured":"Swidsinski A, Loening-Baucke V, Mendling W, Dorffel Y, Schilling J, Halwani Z, Jiang XF, Verstraelen H, Swidsinski S. Infection through structured polymicrobial Gardnerella biofilms (StPM-GB). Histol Histopathol. 2014;29(5):567\u201387.","journal-title":"Histol Histopathol"},{"issue":"7","key":"5563_CR29","doi-asserted-by":"publisher","first-page":"e38991","DOI":"10.1371\/journal.pone.0038991","volume":"7","author":"SD Mehta","year":"2012","unstructured":"Mehta SD, Green SJ, Maclean I, Hu H, Bailey RC, Gillevet PM, Spear GT. Microbial diversity of genital ulcer disease in men enrolled in a randomized trial of male circumcision in Kisumu, Kenya. PloS one. 2012;7(7):e38991.","journal-title":"PloS one"},{"issue":"1","key":"5563_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008422","volume":"5","author":"LB Price","year":"2010","unstructured":"Price LB, Liu CM, Johnson KE, Aziz M, Lau MK, Bowers J, Ravel J, Keim PS, Serwadda D, Wawer MJ, et al. The effects of circumcision on the penis microbiome. PLoS One. 2010;5(1):e8422.","journal-title":"PLoS One"},{"issue":"1","key":"5563_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595568","volume":"199","author":"RH Gray","year":"2009","unstructured":"Gray RH, Wawer MJ, Serwadda D, Kigozi G. The role of male circumcision in the prevention of human papillomavirus and HIV infection. J Infect Dis. 2009;199(1):1\u20133.","journal-title":"J Infect Dis"},{"issue":"2","key":"5563_CR32","doi-asserted-by":"publisher","first-page":"e00076","DOI":"10.1128\/mBio.00076-13","volume":"4","author":"CM Liu","year":"2013","unstructured":"Liu CM, Hungate BA, Tobian AA, Serwadda D, Ravel J, Lester R, Kigozi G, Aziz M, Galiwango RM, Nalugoda F, et al. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. mBio. 2013;4(2):e00076.","journal-title":"mBio"},{"issue":"1","key":"5563_CR33","doi-asserted-by":"publisher","first-page":"42 e41","DOI":"10.1016\/j.ajog.2008.07.069","volume":"200","author":"RH Gray","year":"2009","unstructured":"Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, Moulton L, Chen MZ, Sewankambo NK, Kiwanuka N, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstetr Gynecol. 2009;200(1):42 e41\u20137.","journal-title":"Am J Obstetr Gynecol"},{"issue":"1","key":"5563_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/31.1.9","volume":"31","author":"DI Edwards","year":"1993","unstructured":"Edwards DI. Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother. 1993;31(1):9\u201320.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5563_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1517\/14656566.2015.1035255","volume":"16","author":"R Sobel","year":"2015","unstructured":"Sobel R, Sobel JD. Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother. 2015;16(7):1109\u201315.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"5563_CR36","first-page":"22","volume":"9","author":"M Smieja","year":"1998","unstructured":"Smieja M. Current indications for the use of clindamycin: a critical review. Can J Infect Dis. 1998;9(1):22\u20138.","journal-title":"Can J Infect Dis"},{"issue":"1","key":"5563_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14\u201322.","journal-title":"Am J Med"},{"issue":"2","key":"5563_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297\u2013301.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"5563_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/infdis\/167.3.783","volume":"167","author":"JD Sobel","year":"1993","unstructured":"Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis. 1993;167(3):783\u20134.","journal-title":"J Infect Dis"},{"issue":"6","key":"5563_CR40","doi-asserted-by":"publisher","first-page":"622 e621","DOI":"10.1016\/j.ajog.2018.02.017","volume":"218","author":"SL Achilles","year":"2018","unstructured":"Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota. Am J Obstetr Gynecol. 2018;218(6):622 e621\u201310.","journal-title":"Am J Obstetr Gynecol"},{"key":"5563_CR41","doi-asserted-by":"crossref","unstructured":"Peebles K, Kiweewa FM, Palanee-Phillips T, Chappell C, Singh D, Bunge KE, Naidoo L, Makanani B, Jeenarain N, Reynolds D, et al. Elevated risk of bacterial Vaginosis among users of the copper intrauterine device: a prospective longitudinal cohort study. Clin Infect Dis. 2020.","DOI":"10.1093\/cid\/ciaa703"},{"issue":"2","key":"5563_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05563-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T17:03:23Z","timestamp":1605373403000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05563-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5563"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05563-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"17 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study will be conducted in accordance with relevant regulations and researchers will be compliant with Good Clinical Practice. This is a\u00a0multicentre research project, with sites in three Australian states. Ethical and scientific review has been conducted under the National Mutual Acceptance scheme by the Alfred Hospital Human Research Ethics Committee as the administering HREC (43565; local reference: project 506\/18) and HREC responsible for auditing the trial. Trial sites have received ethical approval and research governance authorisation by the Alfred Hospital HREC (506\/18), Family Planning NSW Ethics Committee (reference R2019\u201306), or the South Eastern Sydney Local Health District HREC (SSA reference 19\/G\/053) prior to the study commencing or prior to any protocol amendments being implemented. Therefore, ethical permission has been granted at all sites and patient recruitment has commenced at all sites. All participants will receive oral and written information about the trial and must give their written informed consent to participate. By signing the consent form, participants are consenting to collection and storage of samples for use in this project. They will also be asked if they agree to provide consent for their samples to be stored indefinitely to be used for future research that is closely related to this research project. Participants are free to withdraw at any time and are instructed that their ongoing clinical care will not be affected.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"834"}}